Cargando…
Peptide Receptor Radionuclide Therapy for a Phosphaturic Mesenchymal Tumor
Tumor-induced osteomalacia is a very rare paraneoplastic syndrome. It can be caused by phosphaturic mesenchymal tumor (PMT), a generally benign tumor that produces fibroblast growth factor 23 (FGF-23), which can cause a severe renal phosphate wasting syndrome. Upon complete surgical removal of the t...
Autores principales: | Häfliger, Simon, Seidel, Ann-Katrin, Schoch, Eric, Reichmann, Jan, Wild, Damian, Steinmann-Schwager, Stephanie, Pless, Miklos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772845/ https://www.ncbi.nlm.nih.gov/pubmed/33442358 http://dx.doi.org/10.1159/000510334 |
Ejemplares similares
-
Phosphaturic mesenchymal tumor: Case report
por: Richardson, Adam L., et al.
Publicado: (2019) -
Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant
por: Shiba, Eisuke, et al.
Publicado: (2016) -
Phosphaturic mesenchymal tumor and related wound problem
por: Xiao, Xian, et al.
Publicado: (2018) -
Clinical and imaging features of phosphaturic mesenchymal tumors
por: Chang, Cheng, et al.
Publicado: (2023) -
Unexpected Phosphaturic Mesenchymal Tumor of the Femoral Head
por: Wang, Hui, et al.
Publicado: (2023)